Why Amneal’s new glaucoma generic is drawing fresh attention Amneal Pharmaceuticals (AMRX) has launched bimatoprost ophthalmic solution 0.01%, a generic version of LUMIGAN used to reduce elevated ...
Important ophthalmic treatment expected to be an important growth driver for Amneal’s Affordable Medicines segmentBRIDGEWATER, N.J., April 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results